Home

Karen Flynn

CIK 1553599 · Chief Commercial Officer · last filed 2026-06-26

Karen Flynn is a Chief Commercial Officer who has filed 98 SEC Form 4 insider transactions across 6 companies since 2012. The most recent filing, for STVN, was dated Jun 26, 2026. Across all open-market trades the lifetime net is −$5.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.2M across reported positions. 10 SEC filings were submitted jointly with Recro Pharma, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.18M

Companies

6

Total Filings

98

Lifetime Open-Market Net

-$5.86M

Filer Profile

Reported Address
C/O CATALENT, INC.
14 SCHOOLHOUSE ROAD
SOMERSET, NJ 08873
Related Filers
Recro Pharma, Inc. — 10 joint filings, latest 2019-12-16
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
STVN Director 7,250 $21.12 $153.1K -$25.5K 1 2026-06-26
SHC Director 54,191 $18.48 $1.00M $0 3 2026-05-27
QTRX Director 57,212 $2.46 $141.0K $0 7 2026-01-06
Catalent, Inc. (CTLT) Delisted Chief Commercial Officer 24,339 $63.48 $1.55M -$577.0K 10 2023-10-31
Societal CDMO, Inc. (REPH) Delisted Director 39,283 $2.09 $82.1K $5.4K 9 2019-12-16
WST Sr VP & Chief Commercial Offic 24,989 $355.66 $8.89M -$5.27M 68 2019-02-21

Recent Filings

98 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-26 STVN Mixed +3,482 -$25.5K EDGAR
2026-05-27 SHC Grant (A) +14,970 $0 EDGAR
2026-01-06 QTRX Grant (A) +23,372 $0 EDGAR
2025-05-27 SHC Grant (A) +19,132 $0 EDGAR
2025-01-06 QTRX Grant (A) +7,435 $0 EDGAR
2024-05-29 SHC Grant (A) +20,089 $0 EDGAR
2024-01-04 QTRX Grant (A) +2,947 $0 EDGAR
2023-10-31 Catalent, Inc. (CTLT) Delisted Grant (A) +6,993 $0 EDGAR
2023-01-04 QTRX Grant (A) +9,001 $11.8K EDGAR
2022-10-31 Catalent, Inc. (CTLT) Delisted Grant (A) +4,149 $0 EDGAR
Showing 1–10 of 98
Page 1 of 10
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.